ACTIVE

KINE GIJBELS ERIK

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result44,5 k €-21,2 %over 1 year
Gross margin81,1 k €-28,9 %over 1 year
Equity315,6 k €+2,7 %over 1 year

Identity

Source · BCE/KBO

KINE GIJBELS ERIK is a Private limited company incorporated in 2009. Its main activity is: Other human health activities. Its registered office is in Rotselaar.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0816.559.559
Incorporation
23/06/2009
Legal form
Private limited company
Registered office
Steenweg op Nieuwrode 57
3111 Rotselaar · FlandreSee on map
Contributed capital
60 000,00 €
Latest accounts
31/12/2025
Contacts
2 public details availableLog in to view
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 16 filings

Trend over 16 financial years

20252024202320222021
Income statement
Gross margin81,1 k €114,1 k €78,8 k €111 k €103,4 k €
EBITDA78,7 k €108,3 k €75 k €109,3 k €101,4 k €
Operating result55,8 k €77,2 k €46,9 k €79,2 k €67,8 k €
Net result44,5 k €56,4 k €30,5 k €51,6 k €44,1 k €
Balance sheet
Equity315,6 k €307,3 k €272,1 k €293,5 k €294 k €
Total assets403,8 k €395,8 k €410,3 k €463,9 k €475,9 k €
Cash267,9 k €237,7 k €65 k €259,6 k €235,5 k €
Debts86,9 k €88,4 k €137,3 k €170,2 k €180,8 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 4 ended

Active mandates

RESPIRO MEDI

Director · 1036.127.175

Represented by Erik Gijbels

Active

Ended mandates

Erik Gijbels

Director

Ended
Erik Gijbels

Manager

Ended
Erik Philomena M Gijbels

Director

Ended
Erik Philomena M Gijbels

Manager

Ended

Other companies at this address

Steenweg op Nieuwrode 57 3111 Rotselaar
CompanyCBE no.
Kine Gijbels Eenheid● Active
0715.899.392
Respiro Invest● Active
0694.855.441

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date30/06/202603/09/202522/08/202421/08/202301/07/202207/07/2021
General meeting01/06/202631/05/202531/05/202431/05/202331/05/202231/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 16 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202501/06/202630/06/2026DutchPDF
Micro model31/12/202431/05/202503/09/2025DutchPDF
Micro model31/12/202331/05/202422/08/2024DutchPDF
Micro model31/12/202231/05/202321/08/2023DutchPDF
Micro model31/12/202131/05/202201/07/2022DutchPDF
Micro model31/12/202031/05/202107/07/2021DutchPDF
Micro model31/12/201931/07/202004/09/2020DutchPDF
Micro model31/12/201831/05/201912/07/2019DutchPDF
Micro model31/12/201730/06/201831/08/2018DutchPDF
Abridged model31/12/201631/05/201731/07/2017DutchPDF
Abridged model31/12/201531/05/201620/07/2016DutchPDF
Abridged model31/12/201401/06/201529/06/2015DutchPDF
Abridged model31/12/201331/05/201430/06/2014DutchPDF
Abridged model31/12/201215/06/201312/07/2013DutchPDF
Abridged model31/12/201131/05/201226/06/2012DutchPDF
Abridged model31/12/201031/05/201117/06/2011DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 4 ended

Active mandates

RESPIRO MEDI

Director · 1036.127.175

Represented by Erik Gijbels

Active

Ended mandates

Erik Gijbels

Director

Ended
Erik Gijbels

Manager

Ended
Erik Philomena M Gijbels

Director

Ended
Erik Philomena M Gijbels

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates30/06/2026
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates16/12/2020
    WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN - KAPITAAL - AANDELEN
    PDF
  • Other24/05/2011
    DOEL - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Other09/07/2009
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202544,5 k €↓
  2. 2024
    Annual accounts 202456,4 k €↑
  3. 2023
    Annual accounts 202330,5 k €↓
  4. 2022
    Annual accounts 202251,6 k €↑
  5. 2021
    Annual accounts 202144,1 k €↑
  6. 2020
    Annual accounts 20206,5 k €↑
  7. 2019
    Annual accounts 2019-14,4 k €↓
  8. 2018
    Annual accounts 201821,2 k €↓
  9. 2017
    Annual accounts 201751,9 k €↓
  10. 2016
    Annual accounts 201652,1 k €↓
  11. 2015
    Annual accounts 201553,9 k €↑
  12. 2014
    Annual accounts 201440 k €↓
  13. 2013
    Annual accounts 201366,7 k €↑
  14. 2012
    Annual accounts 201234,4 k €↑
  15. 2011
    Annual accounts 201113,1 k €↓
  16. 2010
    Annual accounts 201041,6 k €
  17. 23/06/2009
    IncorporationPrivate limited company